Project Grant R21EB035705

Award Date 1/15/25
Completion Date 12/31/27
Dollars Obligated $185K
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop new methods for incorporating the radioisotope fluorine-18 into complex molecules. The $174,375 award, effective December 5, 2024 through November 30, 2027, will support research at The Johns Hopkins University to explore the use of metal-centered fluorination to...
This $692,072 Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) will fund the development of a novel theranostic platform using PSMA-targeted poly(amidoamine) (PAMAM) dendrimers for the management of prostate cancer. The key products to be delivered include: PSMA-targeted theranostic agents that enable highly specific targeting, quantitative PET/CT imaging for patient selection, and delivery of potent antimitotic agents....
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to create a new surgical probe prototype for laparoscopic prostate cancer resection procedures. The $161,000 award will fund the development and testing of a probe specifically designed for use with Positron Emission Tomography (PET) radiotracers, which can better...
The federal Project Grant award R56EB033347, in the amount of $499,291.00, was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The award will support the development of breakthrough technology to enable future compact, mid-field (0.7 Tesla) magnetic resonance imaging (MRI) systems, with the goal of improving accessibility and...
This Project Grant award from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) to the Regents of the University of Michigan aims to develop a real-time functional photoacoustic imaging platform to accurately detect and characterize the aggressiveness of prostate cancer. The $568,151 award, effective February 3, 2025 through January 31, 2030, will support the optimization of photoacoustic contrast agents, evaluation of the imaging platform in mouse models, and...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $277,033 to the University of Cincinnati to develop novel approaches for introducing radiolabeled trifluoromethyl groups into PET tracers. The key objectives are to: 1) create a general strategy to transform alkyl halides into alkyl-[11C]CF3 and alkyl-[18F]CF3...
This Project Grant award, valued at $350,242 and awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will fund the development of a novel, rapid, and memory-efficient open-source software for radiofrequency (RF) coil modeling in magnetic resonance imaging (MRI). The project aims to address challenges with ultra-high field (>3T) MRI scanners,...
The federal Project Grant award R01EB035144, funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will develop a novel molecular imaging technology that combines positron emission tomography (PET) and ultrasound (US) imaging. The $1,541,316 award, with a period of performance from Sep 1, 2024 to May 31, 2028, aims to create a compact PET device with a...
This Project Grant award of $1,302,368 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) will establish a National Center for Biomedical Imaging and Bioengineering at the University of Michigan. The center will develop microsystems-based imaging technologies, including miniature scanners, actuators, and sensors for fiber-coupled microendoscopes to enable...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $185,625 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop a novel magnetic resonance imaging (MRI) excitation technique. The project aims to address the flip angle inhomogeneity problem in high-field 7 Tesla MRI...

This federal Project Grant award of $185,171 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) will support research to optimize polymeric chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) agents for prostate cancer detection. The research aims to synthesize and characterize CEST MRI agents with varying charge and hydrophilicity to improve the specificity of these agents for detecting benign prostate hyperplasia, which can mimic prostate cancer in PSMA PET imaging. The research will involve in vitro testing of agent uptake and internalization in cell lines, as well as in vivo evaluation of agent uptake in mouse models. The project will run from January 2025 through December 2027 and is being conducted by researchers at The Johns Hopkins University.

Generated 7/15/25, 1:52 AM